NAPOLY LLC was founded in 2014 in Russia to develop, manufacture, and sell innovative wound dressings and plasters. Their flagship product, ChitoPran®, is a wound dressing made of chitosan nanofibers that promotes wound healing without needing removal. It has received Russian registration and patent and is manufactured in Russia with an annual production capacity of 30 million units. NAPOLY aims to supply ChitoPran® to medical facilities and pharmacies across Russia and through their online store.

1. Development, manufacturing and sales of
game changing wound dressings and plasters

2. NAPOLY LLC was founded in April 2014
Founders: Seed Fund RVC, Biotechfarm CJSC, MSU Science Park and individuals
Product: ChitoPran® wound dressing
Registration certificate: № 2012/14071 dated August 26, 2014
Patent in Russia: № 252216
Manufacturing: Techno park Strogino & NPM CJSC, full manufacturing cycle in
Russia
Production capacity: 30 mln. items per year
NAPOLY LLC owns the Moscow innovational passport № 301
Current stage : sale
 Tender activities in order to supply its products to the various medical clinics
and hospitals throughout the territory of Russia;
 Pharmacies in Russia;
 On-line store.
Summary
2

3.  complex effect on wound
 no need to remove
 reduction of toxicity
New progressive approach to
management of the wounds
A human hair (80 microns) on the left and
pollen (30 microns) on the right on a
background of material of nanofibers (100 nm)
 the biological activity of chitosan
 nanofibrous layer structure
 additional biological effect of drugs
 high bioavailability of drug substances
Uniqueness
3

4. Product
ChitoPran® - indications for use:
 Treatment of torn, punctured,
incised wounds.
 Treatment of sluggish
granulating wounds, nonhealing
wounds in the step of regeneration,
burns II - III degrees, trophic ulcers, bedsores, frostbite.
 Temporary closure of burn wounds of IIIb degree to prepare them for
autodermoplasty.
 Closing of donor sites.
 Closing of capillary bleeding sections .
 Bedsores in places of pressing dentures.
 During the circumcision.
 Children's wards in clinics and hospitals. 4

5. 5
Official papers
Registration Certificate of
Medical Product
Patent in Russia

6. 6
Manufacturing technology
Submicron fibers in the form of ribbons
Administering the antibiotic
in the spinning solution
ELECTRO-
SPINNING
STERILIZATION
THERMO
PROCESSING
Increasing of strength
Timing control of dissolution
Radiation

7. Clinical observations
Dynamics of a donor wound healing using ChitoPran®
1) Donor wound 2) Imposition of biocover
3) Donor wound after 13 days
Donor wound,
male, 25 years
7

8. More than 80
distributors in Russia
Full cycle
Medical clinics, hospitals Pharmacies
MANUFACTURING
SALE
Individuals
Own system of
distribution
NAPOLY’s
on-line store
Business model
Wholesale
8
KATREN

9. - 19,9 mln.rub.
37,5 mln.rub.
(30 000 000)
(15 000 000)
-
15 000 000
30 000 000
45 000 000
1 кв.14 1 кв.15 1 кв.16 1 кв.17 1 кв.18
Выручка Расходы Прибыль накопленным итогом
Payback period = 4 years
Financial plan
Profit accumulatedRevenue Expenses
9

10. -30
-10
10
30
50
0 1 2 3 4 5 6 7
Traditional funds
Billion, $
Global market - $12 billion
Marketgrowth,%
Modern dressings / coating
Antimicrobial dressings
An increase of 30% per year
International market place dressings
ChitoPran®
10

11. 11
Competitors
WHO?
WHEN? After coverage of the Russian and
CIS markets, 2018

12. Ivan Afanasov
Ph.D., Co-owner
Our team
Tatiana Yudanova
D.Sc., developer
Sergey Brusov
CEO
Olga Titova
Developer, promoter
Dmitry Perminov
Co-owner
Oleg Kareev
EU and SEA customer
development manager
12